Search

everythinglearnresearchcommunity

for

Search:↓

The current understanding of frontal fibrosing alopecia involves immune, genetic, hormonal factors, and possibly environmental triggers, but more research is needed for effective treatments.

The mineralocorticoid receptor may play a role in skin and hair health and could be a new target for treating related disorders.

Araliadiol may promote hair growth like minoxidil without being toxic.

A substance called 15-deoxy prostaglandin J2 can cause hair follicle cells to die, which might explain how prostaglandin D2 can lead to hair loss.

New treatments and early diagnosis methods for permanent hair loss due to scar tissue are important for managing its psychological effects.

Women generally handle heart enlargement better than men, but it's riskier for them if it occurs; hormones like estrogen offer some protection.

The document concludes that proper diagnosis and FDA-approved treatments for different types of hair loss exist, but treatments for severe cases often fail and future improvements may focus on hair follicle stem cells.

Targeting the skin's endocannabinoid system could help treat skin disorders.

Central lipohypertrophy in HIV-infected women may lead to shorter eyelashes.

Deleting MED1 in skin cells causes hair loss and skin changes.

The document concluded that more research is needed to find the best treatment for Frontal fibrosing alopecia.

Frontal fibrosing alopecia is a challenging hair loss condition with no known cause or definitive treatment.

Certain hairstyles, diabetes, scalp infections, and vitamin D deficiency may increase the risk of hair loss in Black women; more research is needed for better treatment.

A new plant-based treatment was effective for hair regrowth in women with a specific type of hair loss that didn't respond to usual treatments.

Leptin, a hormone from fat cells, affects immune responses and can influence skin diseases and hair growth.

Frontal fibrosing alopecia is a scarring hair loss condition mainly affecting older women, with no known cause and treatments that may help stabilize hair loss.

Scarring alopecias are complex hair loss disorders that require early treatment to prevent permanent hair loss.

Western diet may cause male pattern baldness; low glycemic diet with magnesium could help.

Foxp3 is crucial for regulatory T cell function, and targeting these cells may help treat immune disorders.

Lower lipin 1β in belly fat is linked to insulin resistance in people with polycystic ovary syndrome.

Leptin affects skin and hair health and may worsen some skin conditions, but more research is needed to understand its full impact.

The study found that the average age of women diagnosed with Frontal Fibrosing Alopecia in Argentina is higher than in other countries, but their symptoms are similar.

Cholesterol-related compounds can stop hair growth and cause inflammation in a type of scarring hair loss.

CRAC channels are crucial for the development and function of specialized immune cells, preventing severe inflammation and autoimmune diseases.

Recent advances in hair loss treatments show significant progress.

Genes and epigenetic changes are important in the development of Polycystic Ovary Syndrome.

A new botanical treatment improved hair growth and symptoms in lichen planopilaris patients.

Human hair follicle stem cells can turn into multiple cell types but lose some of this ability after being grown in the lab for a long time.

The study concluded that immune cells attacking hair follicles cause hair loss in alopecia, with genetics and environment also playing a role, and highlighted the potential of certain treatments.

Certain gene variations might help protect against insulin resistance and glucose intolerance in people with Polycystic Ovary Syndrome.